Webinar
Microbial Community Profiling Webinar
To learn more about how microbial profiling is being used to study human disease, visit the Illumina Metagenomics page.
Microbiome Times
Pharma & Human Health
Neu-REFIX Beta glucan receives rare pediatric disease and orphan drug designations from the FDA for treatment of Duchenne Muscular Dystrophy
GN Corporation’s Neu REFIX Beta glucan, made in Japan has received both Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (US FDA) for treatment of Duchenne […]
Finance
Abolis Biotechnologies Secures €35M to Accelerate R&D in Innovative Biomanufacturing & Microbiome Solutions
Abolis Biotechnologies, a company specializing in industrial solutions using microorganisms, announced the closing of a €35 million financing round led by an international consortium of investors. This funding will fuel the company’s expansion into global […]
Pharma & Human Health
ProDigest Awarded FDA Contract to Provide a Preclinical Gastrointestinal Model: SHIME®
ProDigest has been awarded a contract to provide a SHIME® (Simulator of Human Intestinal Microbial Ecosystem) technology platform for full gut simulation to the US Food and Drug Administration (FDA), National Center for Toxicological Research. […]
Finance
32 Biosciences Emerges from Stealth Mode with New Approach to Gut Microbiome Medicine
32 Biosciences, pronounced “Three Squared Biosciences,” announces its emergence from stealth mode, with new microbiome diagnostic management tools and microbiome-based interventions. The company intends to revolutionize healthcare with its novel approach to gut microbiome medicine. […]
Pharma & Human Health
Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today reports topline clinical data from Cohort 2 of its SER-155 Phase 1b placebo-controlled study in patients undergoing allo-HSCT. In this patient population, infections are […]
Pharma & Human Health
dsm-firmenich secures UK and EU approvals for 3-FL and LNFP-I/2′-FL HMO ingredients
dsm-firmenich, a global innovator in health, nutrition and beauty, today announced the successful approval of its human milk oligosaccharide (HMO): 3-fucosyllactose (3-FL) and lacto-N-fucopentaose I/2′-fucosyllactose (LNFP-I/2′-FL) mixture as novel food ingredients in the United Kingdom […]
Finance
Viome Raises $25M To Launch Diagnostic Division
Viome, a pioneer in microbiome health science and personalized health solutions, today announced a $25 million internal Series D with participation from Khosla Ventures, Bold Capital WRG Ventures, Marc Benioff, and more. This continued support from existing backers […]
Finance
Lallemand inaugurates new research and development laboratories
Lallemand announces the inauguration of its new laboratories in France, increasing its capacity by over 800 square meters. This significant expansion enhances its interdisciplinary research and development capabilities at the Blagnac and Beauzelle sites. The […]
Finance
IBT’s phase III study shows a significant reduction in the secondary endpoint, all-cause mortality
Infant Bacterial Therapeutics has conducted a phase III study comprising 2153 premature infants for five years. The objective of the study has been to show that the company’s drug candidate IBP-9414, a bacterial strain found […]
Finance
ZBiotics Raises $12M Series A to bring genetically engineered probiotic products to market
ZBiotics, the pioneers carving a new category of genetically engineered probiotics, today announced the close of its $12M Series A funding round, led by Spring Tide Capital. The oversubscribed round also includes participation by Access Capital, Seamless Capital, Goat […]